Use of Nevelia Dermal-Epidermal Regenerative Template in the Management of Ischemic Diabetic Foot Postsurgical Wounds.
Biological Dressings
Diabetic Foot
/ diagnosis
Female
France
/ epidemiology
Humans
Ischemia
/ etiology
Limb Salvage
/ instrumentation
Lower Extremity
/ blood supply
Male
Middle Aged
Outcome Assessment, Health Care
Skin, Artificial
Surgical Wound
/ physiopathology
Vascular Surgical Procedures
/ adverse effects
Wound Healing
dermal-epidermal substitutes
diabetes
diabetic foot ulcers
lower extremity wound
wound dressing
wound management
Journal
The international journal of lower extremity wounds
ISSN: 1552-6941
Titre abrégé: Int J Low Extrem Wounds
Pays: United States
ID NLM: 101128359
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
pubmed:
31
1
2020
medline:
29
6
2021
entrez:
31
1
2020
Statut:
ppublish
Résumé
The purpose of this cross-sectional study is evaluate the effectiveness of a dermal-epidermal substitute (DES) composed of 3-dimensional porous matrix of type 1, purified, stabilized, bovin-origin collagen (Nevelia, SYMATESE, Chaponost, France) without a subsequent skin graft in the treatment ischemic postsurgical diabetic foot ulcers. This study group was composed of a sample of consecutive diabetic patients with critical limb ischemia and postsurgical wounds. All patients received a preset limb salvage protocol including the application of the DES, but none received a skin graft. Patients were closely followed until wound healing or different outcome. The outcome measures were healing, nonhealing, major amputation, and death evaluated at 1 and 2 years of follow-up. Forty-one patients were included. The average postsurgical wound area was 69.6 ± 50 cm
Identifiants
pubmed: 31996064
doi: 10.1177/1534734619896460
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM